A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndrome

Michiyo Asano1 Department of Hematology, Tokyo Medical University, Tokyo, Japan

Junko H Ohyashiki2 Department of Advanced Cellular Therapy, Tokyo Medical University, Tokyo, JapanCorrespondence[email protected]

Chiaki Kobayashi-Kawana1 Department of Hematology, Tokyo Medical University, Tokyo, Japan

Tomohiro Umezu1 Department of Hematology, Tokyo Medical University, Tokyo, Japan;3 Department of Molecular Oncology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan

Satoshi Imanishi3 Department of Molecular Oncology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan

Kenko Azuma3 Department of Molecular Oncology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan

Daigo Akahane1 Department of Hematology, Tokyo Medical University, Tokyo, Japan

Hiroaki Fujimoto1 Department of Hematology, Tokyo Medical University, Tokyo, Japan

Yoshikazu Ito1 Department of Hematology, Tokyo Medical University, Tokyo, Japan

Kazuma Ohyashiki1 Department of Hematology, Tokyo Medical University, Tokyo, Japan

show all

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndrome

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndrome

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date